Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CODEXIS, INC.CDXS · Entity 6428 | Director | June 11, 2024 | June 13, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CODEXIS, INC.
Report date June 11, 2024 · Filed June 13, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 223,581 |
Reported balance
After 2024-06-11 transaction · row 1
1 source rowRow 1 · 2024-06-11 · Grant · Acquired 30,120 · Balance 223,581 F1: The restricted stock award vests as to all of the shares subject to the award on the earlier of the first anniversary of the date of grant or the next annual stockholder meeting, subject to the director's continued service to the Company on such vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: The restricted stock award vests as to all of the shares subject to the award on the earlier of the first anniversary of the date of grant or the next annual stockholder meeting, subject to the director's continued service to the Company on such vesting date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 11, 2024 Filed Jun 13, 2024 22:25 UTC | CODEXIS, INC. CDXS · Entity 6428 | GrantCommon Stock | 30,120 | $0.00 | $0.00 |
DisclosureSEC source: 0000905148-24-001715 · form4.xml · nonDerivative · entry 1 Dorgan Byron L · CIK 0001513219 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 223,581 F1 · shares: The restricted stock award vests as to all of the shares subject to the award on the earlier of the first anniversary of the date of grant or the next annual stockholder meeting, subject to the director's continued service to the Company on such vesting date. Read SEC document |
| November 15, 2023 Filed Nov 17, 2023 22:14 UTC | CODEXIS, INC. CDXS · Entity 6428 | SaleCommon Stock | 20,000 | $2.11 | $42,168.00 |
DisclosureSEC source: 0000905148-23-001486 · form4.xml · nonDerivative · entry 1 Dorgan Byron L · CIK 0001513219 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 193,461 F1 · price: This transaction was executed in multiple trades in prices ranging from $2.07 to $2.14, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| June 13, 2023 Filed Jun 15, 2023 20:09 UTC | CODEXIS, INC. CDXS · Entity 6428 | GrantCommon Stock | 34,602 | $0.00 | $0.00 |
DisclosureSEC source: 0001610717-23-000161 · form4.xml · nonDerivative · entry 1 Dorgan Byron L · CIK 0001513219 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 213,461 F1 · shares: The restricted stock award vests as to all of the shares subject to the award on the earlier of the first anniversary of the date of grant or the next annual stockholder meeting, subject to the director's continued service to the Company on such vesting date. Read SEC document |
| June 14, 2022 Filed Jun 16, 2022 20:10 UTC | CODEXIS, INC. CDXS · Entity 6428 | GrantCommon Stock | 11,273 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-22-012971 · doc1.xml · nonDerivative · entry 1 Dorgan Byron L · CIK 0001513219 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 178,859 F1 · shares: The restricted stock award vests as to all of the shares subject to the award on the earlier of the first anniversary of the date of grant or the next annual stockholder meeting, subject to the director's continued service to the Company on such vesting date. Read SEC document |
| May 26, 2022 Filed May 27, 2022 20:13 UTC | CODEXIS, INC. CDXS · Entity 6428 | Exercise / conversionStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $3.62 | $0.00 |
DisclosureSEC source: 0001567619-22-011827 · doc1.xml · derivative · entry 2 Dorgan Byron L · CIK 0001513219 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,000 shares Expires 2022-06-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 26, 2022 Filed May 27, 2022 20:13 UTC | CODEXIS, INC. CDXS · Entity 6428 | Exercise / conversionCommon Stock | 20,000 | $3.62 | $72,400.00 |
DisclosureSEC source: 0001567619-22-011827 · doc1.xml · nonDerivative · entry 1 Dorgan Byron L · CIK 0001513219 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 167,586 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 18, 2021 Filed Oct 19, 2021 20:22 UTC | CODEXIS, INC. CDXS · Entity 6428 | SaleCommon Stock | 2,600 | $28.53 | $74,178.00 |
DisclosureSEC source: 0001567619-21-018452 · doc1.xml · nonDerivative · entry 2 Dorgan Byron L · CIK 0001513219 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 147,586 F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 15, 2021. Read SEC document |
| October 18, 2021 Filed Oct 19, 2021 20:22 UTC | CODEXIS, INC. CDXS · Entity 6428 | SaleCommon Stock | 17,400 | $27.86 | $484,683.96 |
DisclosureSEC source: 0001567619-21-018452 · doc1.xml · nonDerivative · entry 1 Dorgan Byron L · CIK 0001513219 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,186 F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 15, 2021. F2 · price: This transaction was executed in multiple trades in prices ranging from $27.31 to $28.24, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| June 15, 2021 Filed Jun 17, 2021 20:16 UTC | CODEXIS, INC. CDXS · Entity 6428 | GrantCommon Stock | 4,796 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-21-012319 · doc1.xml · nonDerivative · entry 1 Dorgan Byron L · CIK 0001513219 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 167,586 F1 · shares: The restricted stock award vests as to all of the shares subject to the award on the earlier of the first anniversary of the date of grant or the next annual stockholder meeting, subject to the director's continued service to the Company on such vesting date. Read SEC document |
| January 21, 2021 Filed Jan 22, 2021 00:29 UTC | CODEXIS, INC. CDXS · Entity 6428 | Exercise / conversionStock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $10.63 | $0.00 |
DisclosureSEC source: 0001567619-21-001351 · doc1.xml · derivative · entry 6 Dorgan Byron L · CIK 0001513219 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 25,000 shares Expires 2021-02-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The shares which are the subject of this Form 4 have been sold pursuant to a Rule 10b5-1 Trading Plan dated September 3, 2020 and were obtained by Mr. Dorgan pursuant to a certain stock option grant from Codexis, Inc. dated February 17, 2011 which expires on February 16, 2021. Read SEC document |
| January 21, 2021 Filed Jan 22, 2021 00:29 UTC | CODEXIS, INC. CDXS · Entity 6428 | SaleCommon Stock | 25,000 | $25.17 | $629,195.00 |
DisclosureSEC source: 0001567619-21-001351 · doc1.xml · nonDerivative · entry 4 Dorgan Byron L · CIK 0001513219 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 162,790 F1 · kind: The shares which are the subject of this Form 4 have been sold pursuant to a Rule 10b5-1 Trading Plan dated September 3, 2020 and were obtained by Mr. Dorgan pursuant to a certain stock option grant from Codexis, Inc. dated February 17, 2011 which expires on February 16, 2021. F3 · price: The transaction was executed in multiple trades in prices ranging from $24.78 to $25.57, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| January 21, 2021 Filed Jan 22, 2021 00:29 UTC | CODEXIS, INC. CDXS · Entity 6428 | Exercise / conversionCommon Stock | 25,000 | $10.63 | $265,750.00 |
DisclosureSEC source: 0001567619-21-001351 · doc1.xml · nonDerivative · entry 3 Dorgan Byron L · CIK 0001513219 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 187,790 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The shares which are the subject of this Form 4 have been sold pursuant to a Rule 10b5-1 Trading Plan dated September 3, 2020 and were obtained by Mr. Dorgan pursuant to a certain stock option grant from Codexis, Inc. dated February 17, 2011 which expires on February 16, 2021. Read SEC document |
| January 20, 2021 Filed Jan 22, 2021 00:29 UTC | CODEXIS, INC. CDXS · Entity 6428 | Exercise / conversionStock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $10.63 | $0.00 |
DisclosureSEC source: 0001567619-21-001351 · doc1.xml · derivative · entry 5 Dorgan Byron L · CIK 0001513219 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2021-02-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The shares which are the subject of this Form 4 have been sold pursuant to a Rule 10b5-1 Trading Plan dated September 3, 2020 and were obtained by Mr. Dorgan pursuant to a certain stock option grant from Codexis, Inc. dated February 17, 2011 which expires on February 16, 2021. Read SEC document |
| January 20, 2021 Filed Jan 22, 2021 00:29 UTC | CODEXIS, INC. CDXS · Entity 6428 | SaleCommon Stock | 25,000 | $26.75 | $668,657.50 |
DisclosureSEC source: 0001567619-21-001351 · doc1.xml · nonDerivative · entry 2 Dorgan Byron L · CIK 0001513219 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 162,790 F1 · kind: The shares which are the subject of this Form 4 have been sold pursuant to a Rule 10b5-1 Trading Plan dated September 3, 2020 and were obtained by Mr. Dorgan pursuant to a certain stock option grant from Codexis, Inc. dated February 17, 2011 which expires on February 16, 2021. F2 · price: The transaction was executed in multiple trades in prices ranging from $26.46 to $27.10, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| January 20, 2021 Filed Jan 22, 2021 00:29 UTC | CODEXIS, INC. CDXS · Entity 6428 | Exercise / conversionCommon Stock | 25,000 | $10.63 | $265,750.00 |
DisclosureSEC source: 0001567619-21-001351 · doc1.xml · nonDerivative · entry 1 Dorgan Byron L · CIK 0001513219 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 187,790 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The shares which are the subject of this Form 4 have been sold pursuant to a Rule 10b5-1 Trading Plan dated September 3, 2020 and were obtained by Mr. Dorgan pursuant to a certain stock option grant from Codexis, Inc. dated February 17, 2011 which expires on February 16, 2021. Read SEC document |
| October 09, 2020 Filed Oct 13, 2020 20:04 UTC | CODEXIS, INC. CDXS · Entity 6428 | Exercise / conversionStock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $10.63 | $0.00 |
DisclosureSEC source: 0001567619-20-017752 · doc1.xml · derivative · entry 6 Dorgan Byron L · CIK 0001513219 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 25,000 shares Expires 2021-02-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The shares which are the subject of this Form 4 have been sold pursuant to a Rule 10b5-1 Trading Plan dated September 3, 2020 and were obtained by Mr. Dorgan pursuant to a certain stock option grant from Codexis, Inc. dated February 17, 2011 which expires on February 16, 2021. Read SEC document |
| October 09, 2020 Filed Oct 13, 2020 20:04 UTC | CODEXIS, INC. CDXS · Entity 6428 | SaleCommon Stock | 25,000 | $13.54 | $338,527.50 |
DisclosureSEC source: 0001567619-20-017752 · doc1.xml · nonDerivative · entry 4 Dorgan Byron L · CIK 0001513219 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 162,790 F1 · kind: The shares which are the subject of this Form 4 have been sold pursuant to a Rule 10b5-1 Trading Plan dated September 3, 2020 and were obtained by Mr. Dorgan pursuant to a certain stock option grant from Codexis, Inc. dated February 17, 2011 which expires on February 16, 2021. F3 · price: The transaction was executed in multiple trades in prices ranging from $13.32 to $13.77, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| October 09, 2020 Filed Oct 13, 2020 20:04 UTC | CODEXIS, INC. CDXS · Entity 6428 | Exercise / conversionCommon Stock | 25,000 | $10.63 | $265,750.00 |
DisclosureSEC source: 0001567619-20-017752 · doc1.xml · nonDerivative · entry 3 Dorgan Byron L · CIK 0001513219 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 187,790 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The shares which are the subject of this Form 4 have been sold pursuant to a Rule 10b5-1 Trading Plan dated September 3, 2020 and were obtained by Mr. Dorgan pursuant to a certain stock option grant from Codexis, Inc. dated February 17, 2011 which expires on February 16, 2021. Read SEC document |
| October 08, 2020 Filed Oct 13, 2020 20:04 UTC | CODEXIS, INC. CDXS · Entity 6428 | Exercise / conversionStock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $10.63 | $0.00 |
DisclosureSEC source: 0001567619-20-017752 · doc1.xml · derivative · entry 5 Dorgan Byron L · CIK 0001513219 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 25,000 shares Expires 2021-02-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The shares which are the subject of this Form 4 have been sold pursuant to a Rule 10b5-1 Trading Plan dated September 3, 2020 and were obtained by Mr. Dorgan pursuant to a certain stock option grant from Codexis, Inc. dated February 17, 2011 which expires on February 16, 2021. Read SEC document |
| October 08, 2020 Filed Oct 13, 2020 20:04 UTC | CODEXIS, INC. CDXS · Entity 6428 | SaleCommon Stock | 25,000 | $13.49 | $337,315.00 |
DisclosureSEC source: 0001567619-20-017752 · doc1.xml · nonDerivative · entry 2 Dorgan Byron L · CIK 0001513219 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 162,790 F1 · kind: The shares which are the subject of this Form 4 have been sold pursuant to a Rule 10b5-1 Trading Plan dated September 3, 2020 and were obtained by Mr. Dorgan pursuant to a certain stock option grant from Codexis, Inc. dated February 17, 2011 which expires on February 16, 2021. F2 · price: The transaction was executed in multiple trades in prices ranging from $12.94 to $13.64, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| October 08, 2020 Filed Oct 13, 2020 20:04 UTC | CODEXIS, INC. CDXS · Entity 6428 | Exercise / conversionCommon Stock | 25,000 | $10.63 | $265,750.00 |
DisclosureSEC source: 0001567619-20-017752 · doc1.xml · nonDerivative · entry 1 Dorgan Byron L · CIK 0001513219 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 187,790 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The shares which are the subject of this Form 4 have been sold pursuant to a Rule 10b5-1 Trading Plan dated September 3, 2020 and were obtained by Mr. Dorgan pursuant to a certain stock option grant from Codexis, Inc. dated February 17, 2011 which expires on February 16, 2021. Read SEC document |
| June 16, 2020 Filed Jun 18, 2020 20:14 UTC | CODEXIS, INC. CDXS · Entity 6428 | GrantCommon Stock | 8,952 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-20-012370 · doc1.xml · nonDerivative · entry 1 Dorgan Byron L · CIK 0001513219 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 162,790 F1 · shares: Restricted stock. The shares vest on the earlier of June 16, 2021 or the date of the Issuer's 2021 annual meeting of stockholders. Read SEC document |
| February 21, 2020 Filed Feb 25, 2020 23:02 UTC | CODEXIS, INC. CDXS · Entity 6428 | SaleCommon Stock | 16,702 | $14.02 | $234,192.10 |
DisclosureSEC source: 0001567619-20-004839 · doc1.xml · nonDerivative · entry 1 Dorgan Byron L · CIK 0001513219 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 153,838 F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 12, 2019. F2 · price: This transaction was executed in multiple trades in prices ranging from $14.00 to $14.07, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| December 12, 2019 Filed Dec 13, 2019 21:10 UTC | CODEXIS, INC. CDXS · Entity 6428 | SaleCommon Stock | 25,000 | $15.64 | $390,972.50 |
DisclosureSEC source: 0001567619-19-023067 · doc1.xml · nonDerivative · entry 1 Dorgan Byron L · CIK 0001513219 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 170,540 F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person. F2 · price: This transaction was executed in multiple trades in prices ranging from $15.40 to $15.90, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| June 11, 2019 Filed Jun 13, 2019 20:12 UTC | CODEXIS, INC. CDXS · Entity 6428 | GrantCommon Stock | 4,947 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-013333 · doc1.xml · nonDerivative · entry 1 Dorgan Byron L · CIK 0001513219 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 195,540 F1 · shares: Restricted stock. The shares vest on the earlier of June 11, 2020 or the date of the Issuer's 2020 annual meeting of stockholders. Read SEC document |
| July 16, 2018 Filed Jul 17, 2018 22:37 UTC | CODEXIS, INC. CDXS · Entity 6428 | SaleCommon Stock | 10,000 | $15.49 | $154,880.00 |
DisclosureSEC source: 0001140361-18-032740 · doc1.xml · nonDerivative · entry 1 Dorgan Byron L · CIK 0001513219 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 190,593 F1 · kind: Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on June 14, 2018. F2 · price: This transaction was executed in multiple trades in prices ranging from $15.15 to $15.70, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| June 11, 2018 Filed Jun 13, 2018 01:03 UTC | CODEXIS, INC. CDXS · Entity 6428 | GrantCommon Stock | 5,923 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-18-028293 · doc1.xml · nonDerivative · entry 1 Dorgan Byron L · CIK 0001513219 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,593 F1 · shares: Restricted stock. The shares vest on the earlier of June 11, 2019 or the date of the Issuer's 2019 annual meeting of stockholders. Read SEC document |
| June 14, 2017 Filed Jun 16, 2017 22:48 UTC | CODEXIS, INC. CDXS · Entity 6428 | GrantCommon Stock | 17,894 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-025419 · doc1.xml · nonDerivative · entry 1 Dorgan Byron L · CIK 0001513219 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 194,670 F1 · shares: Restricted stock. The shares vest on the earlier of June 14, 2018 or the date of the Issuer's 2017 annual meeting of stockholders. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.